Connect with us
The omicron variant is now the most dominant strain of SARS-CoV-2 in the U.S. With this latest development in the ongoing pandemic, many people fear the...
CEO Daily readers on the potential risks—and the rewards—of 2022 | Fortune You need to enable JavaScript to view this site.
Don’t lose hope when it comes to the winter COVID surge: Vaccines have boosted our chances | Fortune You need to enable JavaScript to view this...
More data on the omicron variant are slowly trickling in as scientists and medical experts continue to examine the strain rapidly spreading in many parts of...
As COVID deaths top 800,000, Delta and Omicron variants drive new cases | Fortune You need to enable JavaScript to view this site.
The omicron variant of COVID is now spreading rapidly. Early reports suggest omicron causes less severe disease than other variants but it still poses a risk...
In the age of Omicron, should holiday parties be back on the table? | Fortune You need to enable JavaScript to view this site.
Researchers found that the two-dose vaccines from Pfizer and AstraZeneca are not that effective in providing protection against the omicron variant. An Alarming Discovery In a...
Scientists around the world have been racing to learn more about the new omicron strain of SARS-CoV-2, first declared a “variant of concern” on Nov. 26,...
At-home defense: why widespread rapid at-home testing is key to curbing the pandemic | Fortune You need to enable JavaScript to view this site.
Recent Comments